Mobile Health to Improve Adherence and Patient Experience in Heart Transplantation Recipients: The mHeart Trial

Non-adherence after heart transplantation (HTx) is a significant problem. The main objective of this study was to evaluate if a mHealth strategy is more effective than standard care in improving adherence and patients’ experience in heart transplant recipients. Methods: This was a single-center, ran...

Full description

Bibliographic Details
Main Authors: Mar Gomis-Pastor, Sonia Mirabet Perez, Eulalia Roig Minguell, Vicenç Brossa Loidi, Laura Lopez Lopez, Sandra Ros Abarca, Elisabeth Galvez Tugas, Núria Mas-Malagarriga, Mª Antonia Mangues Bafalluy
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Healthcare
Subjects:
Online Access:https://www.mdpi.com/2227-9032/9/4/463
Description
Summary:Non-adherence after heart transplantation (HTx) is a significant problem. The main objective of this study was to evaluate if a mHealth strategy is more effective than standard care in improving adherence and patients’ experience in heart transplant recipients. Methods: This was a single-center, randomized controlled trial (RCT) in adult recipients >1.5 years post-HTx. Participants were randomized to standard care (control group) or to the mHeart Strategy (intervention group). For patients randomized to the mHeart strategy, multifaceted theory-based interventions were provided during the study period to optimize therapy management using the mHeart mobile application. Patient experience regarding their medication regimens were evaluated in a face-to-face interview. Medication adherence was assessed by performing self-reported questionnaires. A composite adherence score that included the SMAQ questionnaire, the coefficient of variation of drug levels and missing visits was also reported. <b>Results</b>: A total of 134 HTx recipients were randomized (intervention N = 71; control N = 63). Mean follow-up was 1.6 (SD 0.6) years. Improvement in adherence from baseline was significantly higher in the intervention group versus the control group according to the SMAQ questionnaire (85% vs. 46%, OR = 6.7 (2.9; 15.8), <i>p</i>-value < 0.001) and the composite score (51% vs. 23%, OR = 0.3 (0.1; 0.6), <i>p</i>-value = 0.001). Patients’ experiences with their drug therapy including knowledge of their medication timing intakes (<i>p</i>-value = 0.019) and the drug indications or uses that they remembered (<i>p</i>-value = 0.003) significantly improved in the intervention versus the control group. <b>Conclusions</b>: In our study, the mHealth-based strategy significantly improved adherence and patient beliefs regarding their medication regimens among the HTx population. The mHeart mobile application was used as a feasible tool for providing long-term, tailor-made interventions to HTx recipients to improve the goals assessed.
ISSN:2227-9032